Adrenal Adenoma vs Carcinoma: Diagnostic OmpathStudy

This document outlines key distinctions between adrenal adenoma and adrenal carcinoma, emphasizing diagnostic criteria and prognosis. It also details the genetic basis and clinical manifestations of Multiple Endocrine Neoplasia (MEN) syndromes, alongside a comparison of parathyroid cell types. Furthermore, it differentiates various forms of Renal Tubular Acidosis (RTA) by their defects and electrolyte abnormalities, and thoroughly describes the pathogenesis and morphological progression of diabetic nephropathy, highlighting critical clinical stages and diagnostic features. Key Points Adrenal carcinoma diagnosis relies exclusively on vascular invasion, capsular invasion, or metastasis , as cytology alone is insufficient. MEN1 is characterized by tumors of the Parathyroid, Pancreas, and Pituitary , while MEN2A and MEN2B involve the Phaeochromocytoma and Medullary Thyroid Carcinoma with distinct additional features. Chief cells are the predominant and functional cells of the parathyroid gland, responsible for PTH synthesis and secretion. Type 4 Renal Tubular Acidosis is uniquely identified by hyperkalaemia , distinguishing it from other RTA types which present with hypokalaemia. Microalbuminuria is the earliest detectable clinical sign of diabetic nephropathy, preceding significant GFR decline. Nodular glomerulosclerosis , specifically Kimmelstiel-Wilson nodules, is a pathognomonic morphological finding for diabetic nephropathy. Prophylactic thyroidectomy is a critical intervention for RET mutation carriers in MEN2 syndromes due to the high risk of medullary thyroid carcinoma. ACE inhibitors and ARBs play a crucial role in managing diabetic nephropathy by reducing intraglomerular pressure. Detailed Notes ADRENAL NEOPLASMS — Adenoma vs Carcinoma Feature Adenoma Carcinoma --- --- --- Size Small, <50g Large, often 100g Gross Yellow, well-circumscribed, smooth Grey-white, irregular, necrotic Histology Uniform clear cells, thin capsule, no invasion Pleomorphic cells, mitoses, necrosis, vascular invasion Capsule Intact Breached — invasion is diagnostic Metastasis No Yes — only reliable criterion of malignancy alongside invasion CDC73/parafibromin Intact Mutated in ~70% ACTH Suppressed (autonomous cortisol) Suppressed Prognosis Excellent after adrenalectomy Poor — local recurrence in 1/3, distant metastasis in 1/3 Cytology alone cannot diagnose carcinoma. Only vascular invasion, capsular invasion, or metastasis confirms malignancy. MEN SYNDROMES (Multiple Endocrine Neoplasia) Feature MEN1 MEN2A MEN2B --- --- --- --- Gene MEN1 (chromosome 11q13, tumour suppressor) RET proto-oncogene RET proto-oncogene Parathyroid Hyperplasia/adenoma ✅ Hyperplasia ✅ No Pancreas Islet cell tumours (gastrinoma, insulinoma) ✅ No No Pituitary Adenoma (prolactinoma most common) ✅ No No Adrenal No Phaeochromocytoma ✅ Phaeochromocytoma ✅ Thyroid No Medullary thyroid carcinoma ✅ Medullary thyroid carcinoma ✅ Other — — Marfanoid habitus, mucosal neuromas Mnemonic: The MEN syndromes can be remembered by their characteristic tumor patterns. MEN1 is associated with the 3 Ps : Parathyroid hyperplasia/adenoma, Pancreas islet cell tumors (such as gastrinoma or insulinoma), and Pituitary adenomas (most commonly prolactinoma). MEN2A involves Phaeochromocytoma and Medullary Thyroid Carcinoma , along with Parathyroid hyperplasia. MEN2B also features Phaeochromocytoma and Medullary Thyroid Carcinoma , but is distinguished by additional features like Marfanoid habitus and mucosal neuromas , notably without parathyroid involvement. Key points: A MEN1 mutation is found in 30–35% of sporadic parathyroid adenomas, highlighting its broader clinical relevance beyond the full syndrome. Given the high risk of medullary thyroid carcinoma, a RET mutation in MEN2 syndromes necessitates screening of family members, often leading to prophylactic thyroidectomy in carriers to prevent disease progression. It is crucial to always screen patients diagnosed with phaeochromocytoma for MEN2 syndromes, as it is a common component of these genetic conditions. PARATHYROID CELL TYPES Cell Type Size Cytoplasm Function Granules --- --- --- --- --- Chief cells 12–20 μm, predominant Light to dark pink, polygonal PTH synthesis and secretion PTH secretory granules present Oxyphil cells Larger than chief cells Deeply eosinophilic, packed with mitochondria Unknown (transitional/inactive) Sparse/absent secretory granules Key points: Chief cells are the predominant and functional cells of the parathyroid gland, primarily responsible for PTH synthesis and secretion . Oxyphil cells are larger than chief cells, characterized by deeply eosinophilic cytoplasm packed with mitochondria. Their function is largely unknown, though they are thought to be transitional or inactive cells, and their number increases with age, typically appearing after puberty. Stromal fat within the parathyroid gland increases up to approximately age 25, then plateaus at around 30% of the gland's volume. Adenomas of the p